Nuveen Asset Management, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,039,563
+13.5%
258,380
-7.3%
0.00%0.0%
Q2 2023$6,199,873
+115763.8%
278,646
+12.8%
0.00%0.0%
Q1 2023$5,351
+3.7%
247,052
-2.8%
0.00%0.0%
Q4 2022$5,160
-99.9%
254,058
-3.4%
0.00%
-33.3%
Q3 2022$6,744,000
-33.4%
263,044
-38.3%
0.00%
-25.0%
Q2 2022$10,130,000
+16.3%
425,998
+20.4%
0.00%
+33.3%
Q1 2022$8,713,000
+56.1%
353,761
+22.6%
0.00%
+50.0%
Q4 2021$5,582,000
-16.6%
288,639
-15.1%
0.00%0.0%
Q3 2021$6,695,000
-20.5%
340,159
-11.2%
0.00%
-33.3%
Q2 2021$8,425,000
-19.6%
382,935
-13.0%
0.00%0.0%
Q1 2021$10,477,000
-8.6%
440,402
+0.5%
0.00%
-25.0%
Q4 2020$11,460,000
+50.5%
438,088
+0.1%
0.00%
+33.3%
Q3 2020$7,617,000
-30.1%
437,678
-32.4%
0.00%
-25.0%
Q2 2020$10,893,000
+42.4%
647,603
+0.7%
0.00%0.0%
Q1 2020$7,647,000
+38.6%
643,135
+41.1%
0.00%
+100.0%
Q4 2019$5,516,000
-24.7%
455,896
-12.0%
0.00%
-33.3%
Q3 2019$7,324,000
+25.6%
518,158
-0.9%
0.00%
+50.0%
Q2 2019$5,829,000522,7780.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders